{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T22:43:05Z","timestamp":1792190585049,"version":"4.4.0"},"reference-count":28,"publisher":"The Endocrine Society","issue":"7","license":[{"start":{"date-parts":[[2020,5,11]],"date-time":"2020-05-11T00:00:00Z","timestamp":1589155200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,7,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>Higher-but-within-normal thyrotropin (thyroid-stimulating hormone, TSH) is associated with higher risk for differentiated thyroid cancer (DTC) in surgical series. Our recent clinical observations suggest that this is not the case in the presence of autoimmune thyroid disease (AITD). We designed the present study to clarify this controversy.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>We analyzed our prospectively collected database of patients referred for thyroid surgery at 2 tertiary care referral centers in Greece and the United States. We collected data for preoperative TSH, postoperative pathology, and thyroid peroxidase (TPO) antibodies titers. Subjects were subdivided into 2 groups, those with AITD (i.e., lymphocytic thyroiditis) and non-AITD. We excluded subjects with Graves disease, abnormal TSH (&amp;lt; 0.40 or\u2005&amp;gt;\u20054.50 mIU\/mL), or recent use of levothyroxine. We compared the serum TSH among different groups using the Mann-Whitney test.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>A total of 3973 subjects were screened; 1357 met exclusion criteria. After all exclusions, data from 1731 non-AITD subjects and 329 AITD subjects were included in the analysis. AITD subjects had higher TSH than non-AITD subjects (2.09 vs 1.48; P\u2005&amp;lt;\u20050.0001). TSH values were higher in DTC compared with benign histology only in non-AITD subjects (1.65 vs 1.40; P\u2005&amp;lt;\u20050.0001). Progressively higher TSH was associated with higher incidence of DTC only in non-AITD subjects (P\u2005&amp;lt;\u20050.0001). In AITD subjects, TSH was similar between groups with or without DTC (2.02 vs 2.14; P\u2005=\u20050.21).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>TSH concentrations are not associated with the risk of developing DTC in the presence of thyroid autoimmunity, even though this seems to be the case for all other patients.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1210\/clinem\/dgaa237","type":"journal-article","created":{"date-parts":[[2020,5,11]],"date-time":"2020-05-11T22:19:35Z","timestamp":1589235575000},"page":"e2389-e2397","source":"Crossref","is-referenced-by-count":13,"title":["Higher TSH Is Not Associated With Thyroid Cancer Risk in the Presence of Thyroid Autoimmunity"],"prefix":"10.1210","volume":"105","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2804-0859","authenticated-orcid":false,"given":"Rodis D","family":"Paparodis","sequence":"first","affiliation":[{"name":"Private Practice, Patras, Greece"},{"name":"Division of Endocrinology, Diabetes and Metabolism, Department of Medicine and Center for Diabetes and Endocrine Research (CeDER), ProMedica Health System\/University of Toledo, Toledo, Ohio"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dimitra","family":"Bantouna","sequence":"additional","affiliation":[{"name":"Department of Pathology, University of Patras Hospital, Patras, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evangelos","family":"Karvounis","sequence":"additional","affiliation":[{"name":"Department of Endocrine Surgery, Euroclinic Hospital, Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shahnawaz","family":"Imam","sequence":"additional","affiliation":[{"name":"Division of Endocrinology, Diabetes and Metabolism, Department of Medicine and Center for Diabetes and Endocrine Research (CeDER), ProMedica Health System\/University of Toledo, Toledo, Ohio"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2723-331X","authenticated-orcid":false,"given":"Juan Carlos","family":"Jaume","sequence":"additional","affiliation":[{"name":"Division of Endocrinology, Diabetes and Metabolism, Department of Medicine and Center for Diabetes and Endocrine Research (CeDER), ProMedica Health System\/University of Toledo, Toledo, Ohio"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","published-online":{"date-parts":[[2020,5,11]]},"reference":[{"issue":"7","key":"2021122116312304500_CIT0001","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1056\/NEJMp1604412","article-title":"Worldwide thyroid-cancer epidemic? the increasing impact of overdiagnosis","volume":"375","author":"Vaccarella","year":"2016","journal-title":"N Engl J Med."},{"issue":"13","key":"2021122116312304500_CIT0002","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1001\/jama.2017.2719","article-title":"Trends in thyroid cancer incidence and mortality in the United States, 1974-2013","volume":"317","author":"Lim","year":"2017","journal-title":"Jama."},{"issue":"11","key":"2021122116312304500_CIT0003","doi-asserted-by":"crossref","first-page":"4295","DOI":"10.1210\/jc.2006-0527","article-title":"Serum thyrotropin concentration as a novel predictor of malignancy in thyroid nodules investigated by fine-needle aspiration","volume":"91","author":"Boelaert","year":"2006","journal-title":"J Clin Endocrinol Metab."},{"issue":"2","key":"2021122116312304500_CIT0004","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1111\/j.1365-2265.2012.04383.x","article-title":"Correlation of TSH with the risk of paediatric thyroid carcinoma","volume":"77","author":"Chiu","year":"2012","journal-title":"Clin Endocrinol (Oxf)."},{"issue":"3","key":"2021122116312304500_CIT0005","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1159\/000488196","article-title":"High serum thyrotropin concentrations within the reference range: a predictor of malignancy in nodular thyroid disease","volume":"27","author":"Duccini","year":"2018","journal-title":"Med Princ Pract."},{"issue":"4","key":"2021122116312304500_CIT0006","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1210\/jc.2011-2735","article-title":"Serum TSH and risk of papillary thyroid cancer in nodular thyroid disease","volume":"97","author":"Fiore","year":"2012","journal-title":"J Clin Endocrinol Metab."},{"issue":"3","key":"2021122116312304500_CIT0007","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1210\/jc.2007-2215","article-title":"Higher serum thyroid stimulating hormone level in thyroid nodule patients is associated with greater risks of differentiated thyroid cancer and advanced tumor stage","volume":"93","author":"Haymart","year":"2008","journal-title":"J Clin Endocrinol Metab."},{"issue":"3","key":"2021122116312304500_CIT0008","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1111\/cen.12027","article-title":"Higher TSH level is a risk factor for differentiated thyroid cancer","volume":"78","author":"Kim","year":"2013","journal-title":"Clin Endocrinol (Oxf)."},{"issue":"31","key":"2021122116312304500_CIT0009","doi-asserted-by":"crossref","first-page":"49930","DOI":"10.18632\/oncotarget.10236","article-title":"Thyroid functional parameters and correlative autoantibodies as prognostic factors for differentiated thyroid cancers","volume":"7","author":"Li","year":"2016","journal-title":"Oncotarget."},{"issue":"7","key":"2021122116312304500_CIT0010","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1002\/hed.21828","article-title":"Serum thyrotropin as a risk factor for thyroid malignancy in euthyroid subjects with thyroid micronodule","volume":"34","author":"Moon","year":"2012","journal-title":"Head Neck."},{"issue":"6","key":"2021122116312304500_CIT0011","doi-asserted-by":"crossref","first-page":"dju097","DOI":"10.1093\/jnci\/dju097","article-title":"Thyroid-stimulating hormone, thyroglobulin, and thyroid hormones and risk of differentiated thyroid carcinoma: the EPIC study","volume":"106","author":"Rinaldi","year":"2014","journal-title":"J Natl Cancer Inst."},{"issue":"2","key":"2021122116312304500_CIT0012","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1177\/0194599815618388","article-title":"The Usefulness of preoperative thyroid-stimulating hormone for predicting differentiated thyroid microcarcinoma","volume":"154","author":"Shi","year":"2016","journal-title":"Otolaryngol Head Neck Surg."},{"issue":"1","key":"2021122116312304500_CIT0013","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.endonu.2014.06.002","article-title":"Preoperative TSH level and risk of thyroid cancer in patients with nodular thyroid disease: nodule size contribution","volume":"62","author":"Zaf\u00f3n","year":"2015","journal-title":"Endocrinol Nutr."},{"issue":"4-5","key":"2021122116312304500_CIT0014","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.autrev.2014.01.007","article-title":"Hashimoto thyroiditis: clinical and diagnostic criteria","volume":"13","author":"Caturegli","year":"2014","journal-title":"Autoimmun Rev."},{"issue":"10","key":"2021122116312304500_CIT0015","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1177\/000313480507101018","article-title":"Hashimoto thyroiditis coexistent with papillary thyroid carcinoma","volume":"71","author":"Cipolla","year":"2005","journal-title":"Am Surg."},{"issue":"7","key":"2021122116312304500_CIT0016","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1089\/thy.2013.0588","article-title":"Hashimoto\u2019s thyroiditis pathology and risk for thyroid cancer","volume":"24","author":"Paparodis","year":"2014","journal-title":"Thyroid."},{"issue":"10","key":"2021122116312304500_CIT0017","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1056\/NEJM198503073121001","article-title":"Cancer risks in patients with chronic lymphocytic thyroiditis","volume":"312","author":"Holm","year":"1985","journal-title":"N Engl J Med."},{"issue":"3","key":"2021122116312304500_CIT0018","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1210\/jc.2018-01933","article-title":"Thyroid ultrasound and the increase in diagnosis of low-risk thyroid cancer","volume":"104","author":"Haymart","year":"2019","journal-title":"J Clin Endocrinol Metab."},{"issue":"2","key":"2021122116312304500_CIT0019","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1007\/s12020-012-9703-2","article-title":"The incidence and prevalence of thyroid autoimmunity","volume":"42","author":"McLeod","year":"2012","journal-title":"Endocrine."},{"key":"2021122116312304500_CIT0020","first-page":"29","article-title":"2017 Endocrine Autoimmunity.","volume-title":"Greenspan\u2019s Basic and Clinical Endocrinology, 9th edition","author":"Jaume"},{"issue":"4","key":"2021122116312304500_CIT0021","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1677\/ERC-09-0036","article-title":"Lower levels of TSH are associated with a lower risk of papillary thyroid cancer in patients with thyroid nodular disease: thyroid autonomy may play a protective role","volume":"16","author":"Fiore","year":"2009","journal-title":"Endocr Relat Cancer."},{"issue":"2","key":"2021122116312304500_CIT0022","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.ecl.2014.02.012","article-title":"Thyrotropin in the development and management of differentiated thyroid cancer","volume":"43","author":"McLeod","year":"2014","journal-title":"Endocrinol Metab Clin North Am."},{"issue":"1","key":"2021122116312304500_CIT0023","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1111\/j.1365-2265.1992.tb02898.x","article-title":"Suppressive therapy with levothyroxine for solitary thyroid nodules","volume":"36","author":"Reverter","year":"1992","journal-title":"Clin Endocrinol (Oxf)."},{"issue":"1","key":"2021122116312304500_CIT0024","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1089\/thy.2015.0020","article-title":"2015 American Thyroid association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the American Thyroid Association Guidelines task force on thyroid nodules and differentiated thyroid cancer","volume":"26","author":"Haugen","year":"2016","journal-title":"Thyroid."},{"issue":"4","key":"2021122116312304500_CIT0025","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1089\/thy.2019.0347","article-title":"Incidentally discovered papillary thyroid microcarcinomas are more frequently found in patients with chronic lymphocytic thyroiditis than with multinodular goiter or Graves\u2019 Disease","volume":"30","author":"Paparodis","year":"2020","journal-title":"Thyroid."},{"issue":"9255","key":"2021122116312304500_CIT0026","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/S0140-6736(00)04046-0","article-title":"Inflammation and cancer: back to Virchow?","volume":"357","author":"Balkwill","year":"2001","journal-title":"Lancet."},{"issue":"3","key":"2021122116312304500_CIT0027","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1530\/ERC-13-0436","article-title":"Lymphocytic profiling in thyroid cancer provides clues for failure of tumor immunity","volume":"21","author":"Imam","year":"2014","journal-title":"Endocr Relat Cancer."},{"issue":"1","key":"2021122116312304500_CIT0028","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s40425-018-0483-y","article-title":"Nature of coexisting thyroid autoimmune disease determines success or failure of tumor immunity in thyroid cancer","volume":"7","author":"Imam","year":"2019","journal-title":"J Immunother Cancer."}],"container-title":["The Journal of Clinical Endocrinology &amp; Metabolism"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jcem\/advance-article-pdf\/doi\/10.1210\/clinem\/dgaa237\/33202303\/dgaa237.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jcem\/article-pdf\/105\/7\/e2389\/41840789\/jcem_105_7_e2389.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jcem\/article-pdf\/105\/7\/e2389\/41840789\/jcem_105_7_e2389.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,21]],"date-time":"2021-12-21T16:51:58Z","timestamp":1640105518000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/105\/7\/e2389\/5835732"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5,11]]},"references-count":28,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2020,5,11]]},"published-print":{"date-parts":[[2020,7,1]]}},"URL":"https:\/\/doi.org\/10.1210\/clinem\/dgaa237","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2020,7]]},"published":{"date-parts":[[2020,5,11]]}}}